DEA schedule
Is Creon a controlled substance?
Creon contains pancrelipase amylase, pancrelipase lipase and pancrelipase protease. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Creon (pancrelipase amylase, pancrelipase lipase and pancrelipase protease) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and pancrelipase amylase, pancrelipase lipase and pancrelipase protease is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted Creon?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 10 prescription listings from 1 labelers, none with a DEA schedule |
| DEA controlled substances list | pancrelipase amylase, pancrelipase lipase and pancrelipase protease is not on the list |
Creon NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 0032-0045 | Creon | capsule, delayed release | 15000 [USP'U]/1; 3000 [USP'U]/1; 9500 [USP'U]/1 | AbbVie Inc. | None |
| 0032-1203 | Creon | capsule, delayed release | 15000 [USP'U]/1; 3000 [USP'U]/1; 9500 [USP'U]/1 | AbbVie Inc. | None |
| 0032-1224 | Creon | capsule, delayed release pellets | 24000 [USP'U]/1; 76000 [USP'U]/1; 120000 [USP'U]/1 | AbbVie Inc. | None |
| 0032-2636 | Creon | capsule, delayed release pellets | 24000 [USP'U]/1; 76000 [USP'U]/1; 120000 [USP'U]/1 | AbbVie Inc. | None |
| 0032-0046 | Creon | capsule, delayed release pellets | 30000 [USP'U]/1; 6000 [USP'U]/1; 19000 [USP'U]/1 | AbbVie Inc. | None |
| 0032-1206 | Creon | capsule, delayed release pellets | 30000 [USP'U]/1; 6000 [USP'U]/1; 19000 [USP'U]/1 | AbbVie Inc. | None |
| 0032-2637 | Creon | capsule, delayed release pellets | 36000 [USP'U]/1; 180000 [USP'U]/1; 114000 [USP'U]/1 | AbbVie Inc. | None |
| 0032-3016 | Creon | capsule, delayed release pellets | 36000 [USP'U]/1; 180000 [USP'U]/1; 114000 [USP'U]/1 | AbbVie Inc. | None |
| 0032-0047 | Creon | capsule, delayed release pellets | 60000 [USP'U]/1; 12000 [USP'U]/1; 38000 [USP'U]/1 | AbbVie Inc. | None |
| 0032-1212 | Creon | capsule, delayed release pellets | 60000 [USP'U]/1; 12000 [USP'U]/1; 38000 [USP'U]/1 | AbbVie Inc. | None |
Questions
Is Creon a controlled substance?
No. Creon (pancrelipase amylase, pancrelipase lipase and pancrelipase protease) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and pancrelipase amylase, pancrelipase lipase and pancrelipase protease is not on the DEA controlled substances list.
Is Creon a narcotic?
No. Creon (pancrelipase amylase, pancrelipase lipase and pancrelipase protease) is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.